178546-34-4

Basic information

• Product Name: Benzaldehyde, 3-broMo-5-fluoro-2-hydroxy-
• Synonyms: Benzaldehyde, 3-broMo-5-fluoro-2-hydroxy-;3-bromo-5-fluoro-2-hydoxybenzaldehyde
• CAS NO: 178546-34-4
• Molecular Formula: C₇H₄BrFO₂
• Molecular Weight: 219.0078632
• Mol File: 178546-34-4.mol

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: Benzaldehyde, 3-broMo-5-fluoro-2-hydroxy-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzaldehyde, 3-broMo-5-fluoro-2-hydroxy-(178546-34-4)
• EPA Substance Registry System: Benzaldehyde, 3-broMo-5-fluoro-2-hydroxy-(178546-34-4)

Safety Data

• Hazardous Substances Data: 178546-34-4(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
Benzaldehyde, 3-bromo-5-fluoro-2-hydroxy-, is used as a key intermediate in organic synthesis for the production of various chemical compounds. Its unique functional groups allow for versatile reactions, making it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Preparation:
Benzaldehyde, 3-bromo-5-fluoro-2-hydroxyis used as a building block in the preparation of pharmaceuticals. Its presence in the molecular structure can influence the pharmacological properties of the final drug, contributing to the development of new therapeutic agents.
Used in Fine Chemicals Production:
Benzaldehyde, 3-bromo-5-fluoro-2-hydroxy-, is utilized in the production of fine chemicals, which are high-purity chemicals used in various industries, including pharmaceuticals, agriculture, and materials science.
Used in Medicinal Chemistry and Drug Discovery:
Due to its unique structure and functional groups, Benzaldehyde, 3-bromo-5-fluoro-2-hydroxy-, is used in medicinal chemistry for the design and synthesis of new drug candidates. Its potential applications in drug discovery make it a promising compound for the development of novel therapeutics.

Upstream product

• 100-97-0 hexamethylenetetramine 
• 496-69-5 2-bromo-4-fluoro-phenol 
• 50-00-0 formaldehyd 
• 347-54-6 5-fluoro-2-hydroxybenzaldehyde 

Downstream Products

• 913629-79-5 3-Bromo-5-fluoro-benzene-1,2-diol 
• 1009092-61-8 C₄₅H₆₂FN₅O₆ 
• 1009093-66-6 C₃₄H₄₆FN₃O₇ 
• 1009093-65-5 C₂₅H₃₆BrFN₂O₅ 
• 1009093-63-3 C₂₁H₃₁BrFNO₅Si 
• 1009093-64-4 C₁₅H₁₇BrFNO₅ 
• 1009093-62-2 C₁₁H₁₁BrFNO₄ 
• 1009093-61-1 C₈H₉BrFNO₂ 
• 550998-61-3 7-bromo-5-fluoro-1-benzofuran-2-carboxylic acid 
• 1009093-60-0 3-bromo-5-fluoro-2-methoxybenzaldehyde 

Relevant articles and documents

Imidazo ring PAR4 antagonist and medical applications thereof

The invention relates to an imidazo ring compound represented by formula (I) or formula (II), or a pharmaceutically acceptable salt or ester or solvate thereof. The compound disclosed by the inventioncan be used for preparing medicines for preventing or treating thromboembolic diseases.

BENZO-FUSED HETEROCYCLIC DERIVATIVES USEFUL AS AGONISTS OF GPR120

The present invention is directed to benzo-fused heterocyclic derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by GPR120. More particularly, the compounds of the present invention are agonists of GPR120, useful in the treatment of, such as for example, Type II diabetes mellitus.

2-CARBOXAMIDE-7-PIPERAZINYL-BENZOFURAN DERIVATIVES 774

The present invention relates to compounds of formula (I), wherein R1 is heteroaryl or heterocyclyl, optionally substituted;R2 is C1-4alkyl, heterocyclyl, C1-4alkylaryl, C1-4alkylheteroaryl, carbocycl

Compounds and Methods for Inhibiting the Interaction of BCL Proteins with Binding Partners

The invention relates to isoxazolidine containing compounds that bind to bcl proteins and inhibit Bcl function. The compounds may be used for treating and modulating disorders associated with hyperproliferation, such as cancer.

NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE

[From equivalent EP1710233A1] The present invention provides compounds represented by general formula (I): or pharmaceutical acceptable salts thereof, wherein R1 is hydrogen or lower alkyl; R2 is lower alkyl, halo-lower alkyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, arylalkenyl, aryloxy-lower alkyl, heteroaryl, heteroaryl-lower alkyl, etc; R3, R4, R5 and R6 are each hydrogen, halogen, cyano, lower alkyl, halo-lower alkyl, lower alkoxy, hydroxy, aryl, etc; provided that at least one of R3, R4, R5 and R6 is other than hydrogen. Compound (I) of the present invention shows a potent adenosine A2A receptor antagonistic activity, and are useful for treating or preventing a disease mediated by adenosine A2A receptors such as motor function disorders, depression, anxiety disorders, cognitive function disorders, cerebral ischemia disorders, restless legs syndrome and the like.

2-(2-HYDROXYBIPHENYL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE DERIVATIVES AS FACTOR VIIA INHIBITORS

The present invention relates to novel inhibitors of Factors VIIa, IXa, Xa, XIa, in particular Factor VIIa, pharmaceutical compositions comprising these inhibitors, and methods for using these inhibitors for treating or preventing thromboembolic disorders, cancer or rheumatoid arthritis. Processes for preparing these inhibitors are also disclosed.